IP Library › Granted Patent US 11,519,028
Granted Patent B2
US 11,519,028 · App. 17/494,726 · Granted Dec 6, 2022

Compositions and methods for identifying nucleic acid molecules

Inventors: Bernhard Zimmermann (Manteca, CA); Ryan Swenerton (San Bruno, CA); Matthew Rabinowitz (San Francisco, CA); Styrmir Sigurjonsson (San Jose, CA); George Gemelos (Portland, OR); Apratim Ganguly (Daly City, CA); Himanshu Sethi (Sunnyvale, CA)
Assignee: Natera, Inc.
C12Q1/6869C12Q1/6806C12Q2525/179C12Q2535/122C12Q2563/179
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,519,028
App. No.
17/494,726
Granted
Dec 6, 2022
Kind
B2
Abstract

The present disclosure provides methods and compositions for sequencing nucleic acid molecules and identifying individual sample nucleic acid molecules using Molecular Index Tags (MITs). Furthermore, reaction mixtures, kits, and adapter libraries are provided.

Claims (15)

1. A composition comprising: at least 1,000,000 tagged sample nucleic acid molecules, wherein each of the tagged sample nucleic acid molecules comprises (a) a sample nucleic acid segment between 10 and 1,000 nucleotides in length linked to (b) at least one heterologous adaptor segment comprising a Molecular Index Tag (MIT) between 4 and 8 nucleotides in length;

wherein the number of different MITs in the composition is between 10 and 3,000; wherein a ratio of the number of tagged sample nucleic acid molecules in the composition to the number of different MITs is at least 1,000:1; wherein the sequences of different MITs differ from each other by at least 2 nucleotides; wherein the composition comprises at least two copies of each MIT; wherein the number of combinations of any 2 MITs exceeds the number of tagged sample nucleic acid molecules in the composition that spans any particular polymorphic locus in the human genome in the sample nucleic acid segment; wherein the sample nucleic acid segments of the tagged sample nucleic acid molecules are derived from cell-free DNA of a single human blood sample or a fraction thereof; and wherein at least 50% of all cell-free DNA of the human blood sample or fraction thereof are linked to the MITs and present in the composition.

2. The composition of claim 1 , wherein the composition comprises at least 1×10 10 tagged sample nucleic acid molecules.

3. The composition of claim 1 , wherein the number of different MITs in the composition is between 10 and 1,000.

4. The composition of claim 1 , wherein the number of different MITs in the composition is between 100 and 1,000.

5. The composition of claim 1 , wherein a ratio of the number of tagged sample nucleic acid molecules in the composition to the number of different MITs is at least 10,000:1.

6. The composition of claim 1 , wherein a ratio of the number of tagged sample nucleic acid molecules in the composition to the number of different MITs is at least 100,000:1.

7. The composition of claim 1 , wherein the sample nucleic acid segment is between 50 and 500 nucleotides in length.

8. The composition of claim 1 , wherein the composition comprises at least 1,000,000 tagged sample nucleic acid molecules each comprising a first MIT located 5′ to the sample nucleic acid segment and a second MIT located 3′ to the sample nucleic acid segment.

9. The composition of claim 1 , wherein the adaptor segment comprises a double-stranded polynucleotide segment comprising the MIT.

10. The composition of claim 1 , wherein the adaptor segment is a Y-adapter comprising a double-stranded polynucleotide segment comprising the MIT and at least one single-stranded polynucleotide segment, wherein the sequence of each Y-adapter other than the MIT is identical.

11. The composition of claim 10 , wherein the double-stranded polynucleotide segment is between 5 and 25 nucleotides in length not including the MIT, and the single-stranded polynucleotide segment is between 5 and 25 nucleotides in length.

12. The composition of claim 1 , wherein each of the tagged sample nucleic acid molecules further comprise a sample-specific barcode.

13. The composition of claim 1 , wherein each of the tagged sample nucleic acid molecules further comprise clonal amplification and sequencing primer binding sequences.

14. The composition of claim 1 , wherein each of the tagged sample nucleic acid molecules further comprise P5 and P7 sequences.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2021
From: ZIMMERMANN, BERNHARD; SWENERTON, RYAN; RABINOWITZ, MATTHEW; SIGURJONSSON, STYRMIR; GEMELOS, GEORGE; GANGULY, APRATIM; SETHI, HIMANSHU
To: NATERA, INC.
Reel/Frame 057708/0510 →
Continuity (4)
Continuation 16418104 · May 21, 2019
Continuation 15716331 · Sep 26, 2017
Division 15372279 · Dec 7, 2016
Related Publication 20220025455A1 · Jan 27, 2022
Cited By (2)
US 12,644,153 US 12,723,280